An evaluation of the simultaneous use of the levonorgestrel-releasing intrauterine device (LNG-IUS, Mirena®) combined with endometrial ablation in the management of menorrhagia

By Vaughan D.   Byrne P.  

Journal of Obstetrics & Gynaecology, Vol. 32, Iss. 4, 2012-05 ,pp. : 372-374

Informa Healthcare

Access to resources Recommend Favorite

Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen

By Kesim M. D.   Aydin Y.   Atis A.   Mandiraci G.  

Climacteric, Vol. 11, Iss. 3, 2008-01 ,pp. : 252-257

Informa Healthcare

Access to resources Recommend Favorite

Should endometrial hyperplasia be regarded as a reason for abnormal uterine bleeding in users of the intrauterine contraceptive device?

By Özalp S.   Kabukcuoglu S.   Tanir H. M.  

The European Journal of Contraception and Reproductive Health Care, Vol. 8, Iss. 1, 2003-03 ,pp. : 17-20

Informa Healthcare

Access to resources Recommend Favorite

The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review

By Wan Y.-L.   Holland C.  

Climacteric, Vol. 14, Iss. 6, 2011-12 ,pp. : 622-632

Informa Healthcare

Access to resources Recommend Favorite

Endometrial polyp and the levonorgestrel intrauterine system—a case report and literature review

By Sinha A.   Nwosu E. C.  

Journal of Obstetrics & Gynaecology, Vol. 22, Iss. 6, 2002-11 ,pp. : 695-695

Informa Healthcare

Access to resources Recommend Favorite